Home›Companies›Biotech & Pharma›AlmataBio

AlmataBio, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 4, 2023·Suggest an edit

About AlmataBio

AlmataBio is a private company based in Atlanta, Georgia, incorporated in 2023 in Delaware. It has reported $2,129,502 raised in one offering on Form D since December 2023. Its chief executive is Patrick Crutcher.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 22, 2023Dec 4, 2023$2,129,502of $3.9M target4$532KEquity, Debt, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AlmataBio's Form D filed Dec 4, 2023.

JD
Justin DiMartino
Executive officer, director and promoter
PC
Patrick Crutcher
Chief Executive Officer and director

Sources

  1. SECAlmataBio, Inc. filing history